Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $61.01 and traded as high as $66.06. Novozymes A/S shares last traded at $66.00, with a volume of 13,015 shares.
Novozymes A/S Trading Up 2.0%
The business has a 50 day moving average of $61.64 and a 200-day moving average of $59.13. The firm has a market capitalization of $32.07 billion, a P/E ratio of 43.35, a PEG ratio of 3.87 and a beta of 0.92.
Novozymes A/S Increases Dividend
The firm also recently declared a dividend, which was paid on Wednesday, April 23rd. Stockholders of record on Monday, April 7th were paid a dividend of $0.3758 per share. This is a boost from Novozymes A/S's previous dividend of $0.17. The ex-dividend date was Monday, April 7th. Novozymes A/S's dividend payout ratio (DPR) is currently 47.47%.
Novozymes A/S Company Profile
(
Get Free Report)
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
See Also
Before you consider Novozymes A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.
While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.